| |
Resistant Isolates
|
MDR Isolates
|
|---|
|
%
|
95% CI
|
%
|
95% CI
|
|---|
|
Species
| |
n = 123
| |
n = 35
|
|
S. aureus
|
72.5
|
58.3, 83.3a
|
52.9
|
38.5, 67.1a
|
|
S. pseudintermedius
|
38.9
|
19.2, 63.0b
|
16.7
|
3.6, 41.4b
|
|
S. spp
1
|
30.4
|
18.7, 45.4b
|
2.2
|
0.1, 11.5c
|
|
All other species2
|
75.0
|
34.9, 96.8a
|
50.0
|
15.7, 84.3a
|
|
Antimicrobial & Antimicrobial Class
| |
n = 64
| |
n = 35
|
|
Aminoglycosides3
|
|
Gentamycin
|
54.6
|
42.1, 66.7a
|
48.9
|
38.1, 59.8
|
|
Amikacin
|
14.1
|
7.3, 25.2e
|
9.1
|
4.0, 17.1
|
|
Β-lactams4
|
|
Ampicillin
|
84.5
|
72.3, 91.9b
|
37.5
|
27.4, 48.5
|
|
Penicillin
|
74.1
|
61.0, 84.0b
|
37.5
|
27.4, 48.5
|
|
Ceftriaxone
|
44.8
|
32.3, 58.1c
|
30.0
|
20.3, 41.3
|
|
Fluoroquinolones5
|
|
Enrofloxacin
|
23.4
|
14.5, 35.7c
|
18.8
|
10.1, 30.5b
|
|
Folate Pathway Inhibitors6
|
|
Trimotherim-sulfamethoxazole
|
60.9
|
48.2, 72.3a
|
53.1
|
40.2, 65.7a
|
|
Tetracyclines7
|
|
Doxycyline
|
46.9
|
34.8, 59.4a,d
|
35.9
|
24.3, 48.9c
|
|
Phenicols
|
|
Chloramphenicol
|
44.1
|
31.7, 57.2d
|
31.3
|
20.2, 44.1c
|
-
1Samples that were not identified to species level and were thus reported as Staphylococcus spp.
-
2Other species included S. equinus, S. chromogens and S. epidermidis
-
3Gentamycin and amikacin
-
4Penicillin, ampicillin, ceftriaxone
-
5Enrofloxacin
-
6Sulphamethoxazole
-
7Chloramphenicol
-
a-dEstimates with different superscripts are significantly different at 5% significance level
